Skip to main content
. 2024 Nov 8;15:1490712. doi: 10.3389/fimmu.2024.1490712

Figure 5.

Figure 5

Therapeutic Interventions Targeting Neutrophils in Osteosarcoma. These include neutralizing chemokine gradients that recruit neutrophils to the TME, pharmacological repolarization of TAN phenotypes using TGF-β inhibitors, and the innovative use of engineered neutrophils for precision drug delivery, highlighting the potential of these approaches to disrupt osteosarcoma progression and enhance therapeutic responses.